For patients who present with an MI and have an LVEF ≥ 50% post-vascularization, the benefit of beta-blockers, if one truly exists, is likely modest at best.
The Canadian Cardiovascular Society recently issued a clinical practice statement on contemporary approaches to smoking cessation. Based on this statement, which point is FALSE?
When patients ask us for alternative ways to lower their blood pressure, pharmacists have the unique opportunity to deliver evidence-based guidance that blends clinical urgency with practical, sustainable lifestyle advice.